| ALZCUR Stock | | | SEK 1.19 0.16 15.53% |
Director
Mr. Pontus Forsell serves as Director Pharmacology at AlzeCure Pharma AB. Pontus Forsell has 20 years of experience from several biotech and pharmaceutical companies, such as Biolipox, Orexo, Merck and AstraZeneca in project and management positions. He is an expert in early phase drug discovery within the disease areas neurology, analgesia, as well as respiratory and inflammation. He has Ph.D. Medical Biochemistry Biophysics at Karolinska Institutet, Sweden.
| Age | 56 |
| Professional Marks | Ph.D |
| Phone | 46 8 52 80 03 99 |
| Web | https://www.alzecurepharma.se |
AlzeCure Pharma Management Efficiency
The company has return on total asset
(ROA) of
(0.7846) % which means that it has lost $0.7846 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
(1.5536) %, meaning that it generated substantial loss on money invested by shareholders. AlzeCure Pharma's management efficiency ratios could be used to measure how well AlzeCure Pharma manages its routine affairs as well as how well it operates its assets and liabilities.
AlzeCure Pharma AB develops therapies for the treatment of Alzheimer s disease and related neurodegenerative disorders. The company was founded in 2012 and is based in Huddinge, Sweden. AlzeCure Pharma is traded on Stockholm Stock Exchange in Sweden. AlzeCure Pharma (ALZCUR) is traded on Stockholm Exchange in Sweden and employs 14 people.
Management Performance
AlzeCure Pharma Leadership Team
Elected by the shareholders, the AlzeCure Pharma's board of directors comprises two types of representatives: AlzeCure Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AlzeCure. The board's role is to monitor AlzeCure Pharma's management team and ensure that shareholders' interests are well served. AlzeCure Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AlzeCure Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
AlzeCure Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AlzeCure Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Other Information on Investing in AlzeCure Stock
AlzeCure Pharma financial ratios help investors to determine whether AlzeCure Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AlzeCure with respect to the benefits of owning AlzeCure Pharma security.